Smith NL, Psaty BM, Furberg CD, et al. Temporal trends in the use of anticoagulants among older adults with atrial fibrillation[J]. Arch Intern Med, 1999, 159:1574-1578. Virjo I, Mäkelä K, Aho J, et al. Who receives anticoagulant treatment with warfarin and why? A population-based study in Finland[J]. Scand J Prim Health Care, 2010, 28:237-241. Lovelock CE, Molyneux AJ, Rothwell PM. Change in incidence and aetiology of intracerebral haemorrhage in Oxfordshire, UK, between 1981 and 2006:a population-based study[J]. Lancet Neurol, 2007, 6:487-493. Flaherty ML, Kissela B, Woo D, et al. The increasing incidence of anticoagulant-associated intracerebral hemorrhage[J]. Neurology, 2007, 68:116-121. Cavallini A, Fanucchi S, Persico A. Warfarin-associated intracerebral hemorrhage[J]. Neurol Sci, 2008, 29:S266-S268. Flaherty ML, Tao H, Haverbusch M, et al. Warfarin use leads to larger intracerebral hematomas[J]. Neurology, 2008, 71:1084-1089. Beyth RJ, Quinn LM, Landefeld CS. Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin[J]. Am J Med, 1998, 105:91-99. Kuijer PM, Hutten BA, Prins MH, et al. Prediction of the risk of bleeding during anticoagulant treatment for venous thromboembolism[J]. Arch Intern Med, 1999, 159:457-460. Shireman TI, Mahnken JD, Howard PA, et al. Development of a contemporary bleeding risk model for elderly warfarin recipients[J]. Chest, 2006, 130:1390-1396. European Heart Rhythm Association; European Association for Cardio-Thoracic Surgery, Camm AJ, Kirchhof P, et al. Guidelines for the management of atrial fibrillation:the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology(ESC)[J]. Eur Heart J, 2010, 31:2369-2429. No authors listed. Bleeding during antithrombotic therapy in atrial fibrillation. The Stroke Prevention in Artial Fibrillation Investigators[J]. Arch Intern Med, 1996, 156:409-416. Charidimou A, Shakeshaft C, Werring DJ. Cerebral microbleeds on magnetic resonance imaging and anticoagulant-associated intracerebral hemorrhage risk[J]. Front Neurol, 2012, 3:133. 林琅, 张微微, 赵秀欣, 等. 脑小血管病对卒中后转归和并发症的影响[J]. 中国卒中杂志, 2009, 4:634-636. Pantoni L. Cerebral small vessel disease:from pathogenesis and clinical characteristics to therapeutic challenges[J]. Lancet Neurol, 2010, 9:689-701. Soo YO, Yang SR, Lam WW, et al. Risk vs benefit of antithrombotic therapy in ischaemic stroke patients with cerebral microbleeds[J]. J Neurol, 2008, 255:1679-1686. Lee SH, Kim BJ, Ryu WS, et al. White matter lesions and poor outcome after intracerebral hemorrhage:a nationwide cohort study[J]. Neurology, 2010, 74:1502-1510. Won YS, Chung PW, Kim YB, et al. Leukoaraiosis predicts poor outcome after spontaneous supratentorial intracerebral hemorrhage[J]. Eur Neuro, 2010, 64:253-257. Hachinski VC, Potter P, Merskey H. Leukoaraiosis[J]. Arch Neurol, 1987, 44:21-23. 郭宏志. 脑白质疏松症[J]. 临床神经病学, 2002, 15:3-5. No authors listed. A randomized trial of anticoagulants versus aspirin after cerebral ischemia of presumed arterial origin. The Stroke Prevention in Reversible Ischemia Trial(SPIRIT) Study Group[J]. Ann Neurol, 1997, 42:857-865. Gorter JW. Major bleeding during anticoagulation after cerebral ischemia:patterns and risk factors. Stroke Prevention In Reversible Ischemia Trial(SPIRIT). European Atrial Fibrillation Trial(EAFT) Study Groups[J]. Neurology, 1999, 53:1319-1327. van Swieten JC, Hijdra A, Koudstaal PJ, et al. Grading white matter lesions on CT and MRI:a simple scale[J]. J Neurol Neurosurg Psychiatry, 1990, 53:1080-1083. Smith EE, Rosand J, Knudsen KA, et al. Leukoaraiosis is associated with warfarin-related hemorrhage following ischemic stroke[J]. Neurology, 2002, 59:193-197. Ay H, Arsava EM, Rosand J, et al. Severity of leukoaraiosis and susceptibility to infarct growth in acute stroke[J]. Stroke, 2008, 39:1409-1413. Roob G, Schmidt R, Kapeller P, et al. MRI evidence of past cerebral microbleeds in a healthy elderly population[J]. Neurology, 1999, 52:991-994. Viswanathan A, Chabirat H. Cerebral microhemorrhage[J]. Stroke, 2006, 37:550-555. Lovelock CE, Cordonnier C, Naka H, et al. Antithrombotic drug use, cerebral microbleeds, and intracerebral hemorrhage:a systematic review of published and unpublished studies[J]. Stroke, 2010, 41:1222-1228. Lee SH, Ryu WS, Roh JK. Cerebral microbleeds are a risk factor for warfarin-related intracerebral hemorrhage[J]. Neurology, 2009, 72:171-176. UeIiO H, Naka H, Ohshita T, et al. Association between cerebral microbleeds on T2-weighted MR images and recurrent hemorrhagic stroke in patients treated with warfarin following ischemic stroke[J]. AJNR Am J Neuroradiol, 2008, 29:1483-1486. Dr David Werring. Clinical Relevance Of Microbleeds In Stroke:Microbleeds and genetic risk factors to predict the risk of intracranial haemorrhage in patients treated with anticoagulation following cardioembolic stroke due to atrial fibrillation[EB/OL]. (2010-12-31)[2013-01-10]. http://public.ukcrn.org.uk/Search/StudyDetail.aspx? |